AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. CINGW
  4. [8-K] Cingulate Inc. Warrants Reports Material Event

[8-K] Cingulate Inc. Warrants Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source:

Stock CINGW logo
Cingulate

NASDAQ:CINGW

CINGW Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

CINGW Latest News

Aug 19, 2025
Cingulate Inc. Reports Second Quarter 2025 Financial Results and Provides Recent Highlights
Aug 15, 2025
Cingulate Provides Management Team Update
Aug 6, 2025
Cingulate Submits New Drug Application to FDA for Lead ADHD Asset CTx-1301
Jul 29, 2025
Cingulate Receives $4.3M Waiver from FDA Ahead of Imminent Filing for Marketing Approval of Lead ADHD Asset CTx-1301
Jul 9, 2025
Cingulate Appoints Nilay Patel as Chief Legal Officer to Support Growth ahead of New Drug Application

CINGW Latest SEC Filings

Aug 19, 2025
[10-Q] Cingulate Inc. Warrants Quarterly Earnings Report
Aug 19, 2025
[8-K] Cingulate Inc. Warrants Reports Material Event
Aug 15, 2025
[DEF 14A] Cingulate Inc. Warrants Definitive Proxy Statement
Aug 15, 2025
[NT 10-Q] Cingulate Inc. Warrants SEC Filing
Aug 15, 2025
[8-K] Cingulate Inc. Warrants Reports Material Event

CINGW Stock Data

3.83M
Biotechnology
Pharmaceutical Preparations
United States
KANSAS CITY